Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Shin, Eunju ^a   Tronci, Elisabetta ^b   Carta, Manolo ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; BUSPIRONE; LEVODOPA; TRANSCRIPTION FACTOR FOSB; VESICULAR MONOAMINE TRANSPORTER;

DISEASE COURSE; DRUG INDUCED DISEASE; DYSKINESIA; GENE SILENCING; GRAFT INDUCED DYSKINESIA; LEVODOPA INDUCED DYSKINESIA; NERVE DEGENERATION; NEUROIMAGING; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC NERVE CELL; TREATMENT RESPONSE;

EID: 84863677359     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/370190     Document Type: Review

References (47)

1. Bézard E., Ferry S., Mach U., Stark H., Leriche L., Boraud T., Gross C., Sokoloff P., Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function Nature Medicine 2003 9 6 762 767 (Pubitemid 36749227)
2. Hill M. P., Bézard E., McGuire S. G., Crossman A. R., Brotchie J. M., Michel A., Grimée R., Klitgaard H., Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset Movement Disorders 2003 18 11 1301 1305 (Pubitemid 38263314)
3. Hsu A., Togasaki D. M., Bézard E., Sokoloff P., Langsten J. W., Di Monte D. A., Quik M., Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys Journal of Pharmacology and Experimental Therapeutics 2004 311 2 770 777 (Pubitemid 39391566)
4. Lundblad M., Andersson M., Winkler C., Kirik D., Wierup N., Cenci M. A., Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease European Journal of Neuroscience 2002 15 1 120 132 (Pubitemid 35478015)
5. Berthet A., Porras G., Doudnikoff E., Stark H., Cador M., Bézard E., Bloch B., Pharmacological analysis demonstrates dramatic alteration of D 1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia Journal of Neuroscience 2009 29 15 4829 4835
6. Guigoni C., Doudnikoff E., Li Q., Bloch B., Bézard E., Altered D 1 dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates Neurobiology of Disease 2007 26 2 452 463 (Pubitemid 46561343)
7. Carlsson T., Carta M., Winkler C., Bjrklund A., Kirik D., Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease Journal of Neuroscience 2007 27 30 8011 8022 (Pubitemid 47173327)
8. Carta M., Carlsson T., Kirik D., Bjrklund A., Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 2007 130 7 1819 1833 (Pubitemid 47343795)
9. Muoz A., Carlsson T., Tronci E., Kirik D., Bjrklund A., Carta M., Serotonin neuron-dependent and -independent reduction of dyskinesia by 5- HT 1A and 5- HT 1B receptor agonists in the rat Parkinson model Experimental Neurology 2009 219 1 298 307
10. Rylander D., Parent M., O-Sullivan S. S., Dovero S., Lees A. J., Bézard E., Descarries L., Cenci M. A., Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia Annals of Neurology 2010 68 5 619 628
11. Zeng B. Y., Iravani M. M., Jackson M. J., Rose S., Parent A., Jenner P., Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia Neurobiology of Disease 2010 40 3 599 607
12. Politis M., Oertel W. H., Wu K., Quinn N. P., Pogarell O., Brooks D. J., Bjorklund A., Lindvall O., Piccini P., Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio Movement Disorders 2011 26 11 1997 2003
13. Politis M., Wu K., Loane C., Quinn N. P., Brooks D. J., Rehncrona S., Bjorklund A., Lindvall O., Piccini P., Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants Science Translational Medicine 2010 2 38
14. Ulusoy A., Sahin G., Kirik D., Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats Proceedings of the National Academy of Sciences of the United States of America 2010 107 29 13159 13164
15. Tanaka H., Kannari K., Maeda T., Tomiyama M., Suda T., Matsunaga M., Role of serotonergic neuron in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats NeuroReport 1999 10 3 631 634 (Pubitemid 29333295)
16. Eskow K. L., Dupre K. B., Barnum C. J., Dickinson S. O., Park J. Y., Bishop C., The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats Synapse 2009 63 7 610 620
17. Lindgren H. S., Andersson D. R., Lagerkvist S., Nissbrandt H., Cenci M. A., L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia Journal of Neurochemistry 2010 112 6 1465 1476
18. Muoz A., Li Q., Gardoni F., Marcello E., Qin C., Carlsson T., Kirik D., Di Luca M., Bjrklund A., Bézard E., Carta M., Combined 5- HT 1A and 5- HT 1B receptor agonists for the treatment of L-DOPA-induced dyskinesia Brain 2008 131 12 3380 3394
19. Navailles S., Benazzouz A., Bioulac B., Gross C., De Deurwaerdre P., High-frequency stimulation of the subthalamic nucleus and L-3,4- dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease Journal of Neuroscience 2010 30 6 2356 2364
20. Navailles S., Bioulac B., Gross C., De Deurwaerdre P., Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease Neurobiology of Disease 2011 41 2 585 590
21. Nevalainen N., Af Bjerken S., Lundblad M., Gerhardt G. A., Stromberg I., Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia Journal of Neurochemistry 2011 118 12 23
22. de La Fuente-Fernndez R., Sossi V., Huang Z., Furtado S., Lu J. Q., Calne D. B., Ruth T. J., Stoessl A. J., Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias Brain 2004 127 12 2747 2754 (Pubitemid 39627382)
23. Gil S., Park C., Lee J., Koh H., The roles of striatal serotonin and l-amino-acid decarboxylase on l-DOPA-induced dyskinesia in a hemiparkinsonian rat model Cellular and Molecular Neurobiology 2010 30 6 817 825
24. de La Fuente-Fernndez R., Schulzer M., Mak E., Calne D. B., Stoessl A. J., Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model Brain 2004 127 4 888 899 (Pubitemid 38478533)
25. Carlsson T., Carta M., Muoz A., Mattsson B., Winkler C., Kirik D., Bjrklund A., Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration Brain 2009 132 2 319 335
26. Freed C. R., Breeze R. E., Rosenberg N. L., Schneck S. A., Kriek E., Qi J. X., Lone T., Zhang Y. B., Snyder J. A., Wells T. H., Ramig L. O., Thompson L., Mazziotta J. C., Huang S. C., Grafton S. T., Brooks D., Sawle G., Schroter G., Ansari A. A., Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease The New England Journal of Medicine 1992 327 22 1549 1555
27. Lindvall O., Sawle G., Widner H., Rothwell J. C., Bjrklund A., Brooks D., Brundin P., Frackowiak R., Marsden C. D., Odin P., Rehncrona S., Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease Annals of Neurology 1994 35 2 172 180 (Pubitemid 24050152)
28. Lindvall O., Widner H., Rehncrona S., Brundin P., Odin P., Gustavii B., Frackowiak R., Leenders K. L., Sawle G., Rothwell J. C., Bjorklund A., Marsden C. D., Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants Annals of Neurology 1992 31 2 155 165
29. Olanow C. W., Goetz C. G., Kordower J. H., Stoessl A. J., Sossi V., Brin M. F., Shannon K. M., Nauert G. M., Perl D. P., Godbold J., Freeman T. B., A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Annals of Neurology 2003 54 3 403 414 (Pubitemid 37072046)
30. Piccini P., Brooks D. J., Bjrklund A., Gunn R. N., Grasby P. M., Rimoldi O., Brundin P., Hagell P., Rehncrona S., Widner H., Lindvall O., Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient Nature Neuroscience 1999 2 12 1137 1140 (Pubitemid 30126374)
31. Lane E. L., Bjrklund A., Dunnett S. B., Winkler C., Neural grafting in Parkinson's disease. Unraveling the mechanisms underlying graft-induced dyskinesia Progress in Brain Research 2010 184 295 309
32. Freed C. R., Greene P. E., Breeze R. E., Tsai W. Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J. Q., Eidelberg D., Fahn S., Transplantation of embryonic dopamine neurons for severe Parkinson's disease The New England Journal of Medicine 2001 344 10 710 719 (Pubitemid 32204988)
33. Hagell P., Piccini P., Bjrklund A., Brundin P., Rehncrona S., Widner H., Crabb L., Pavese N., Oertel W. H., Quinn N., Brooks D. J., Lindvall O., Dyskinesias following neural transplantation in Parkinson's disease Nature Neuroscience 2002 5 7 627 628 (Pubitemid 34742975)
34. Mendez I., Vuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J. Q., Isacson O., Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years Nature Medicine 2008 14 5 507 509 (Pubitemid 351655215)
35. Lane E. L., Winkler C., Brundin P., Cenci M. A., The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat Neurobiology of Disease 2006 22 2 334 345
36. Vinuela A., Hallett P. J., Reske-Nielsen C., Patterson M., Sotnikova T. D., Caron M. G., Gainetdinov R. R., Isacson O., Implanted reuptake-deficient or wild-type dopaminergic neurons improve on L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease Brain 2008 131 12 3361 3379
37. Carlsson T., Winkler C., Lundblad M., Cenci M. A., Bjrklund A., Kirik D., Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia Neurobiology of Disease 2006 21 3 657 668 (Pubitemid 43277547)
38. Zetterstrom T., Herrera-Marschitz M., Ungerstedt U., Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis Brain Research 1986 376 1 1 7 (Pubitemid 16046010)
39. Lane E. L., Vercammen L., Cenci M. A., Brundin P., Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats Experimental Neurology 2009 219 1 355 358
40. Lane E. L., Soulet D., Vercammen L., Cenci M. A., Brundin P., Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease Neurobiology of Disease 2008 32 2 220 228
41. Lane E. L., Brundin P., Cenci M. A., Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease Neurobiology of Disease 2009 35 1 42 51
42. Garcia J., Carlsson T., Dbrssy M., Nikkhah G., Winkler C., Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation Experimental Neurology 2011 232 270 279
43. Shin E., Garcia J., Winkler C., Bjrklund A., Carta M., Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. Neurobiology of Disease. In press
44. Eison A. S., Temple D. L., Buspirone: review of its pharmacology and current perspectives on its mechanism of action American Journal of Medicine 1986 80 3 1 9 (Pubitemid 16097578)
45. McMillen B. A., Matthews R. T., Sanghera M. K., Dopamine receptor antagonism by the novel anti-anxiety drug, buspirone Journal of Neuroscience 1983 3 4 733 738 (Pubitemid 13114090)
46. Rijnders H. J., Slangen J. L., The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity Psychopharmacology 1993 111 1 55 61 (Pubitemid 23101352)
47. Scuvee-Moreau J., Giesbers I., Dresse A., Electrophysiological and microiontophoretic studies with buspirone: influence on the firing rate of central monoaminergic neurons and their responsiveness to dopamine, clonidine or GABA Archives Internationales de Physiologie et de Biochimie 1987 95 5 439 446 (Pubitemid 18073130)